Uropathogenic Escherichia coli isolates with different virulence genes content exhibit similar pathologic influence on Vero cells

• Autorzy: Obaid J.M.A.S. , Monsour S. R. , Elshahedy M. S. , Rabie T. E. , Azab A. M. H.
• Języki publikacji: EN

Abstrakty

EN

Uropathogenic Escherichia coli are the major causative agent of urinary tract infection – they may simultaneously express a number of virulence factors to cause disease. The aim of this study was to investigate the relation between virulence factors content of fifteen UPEC isolates and their pathogenic potential. The isolates belonged to the five serotypes O78:K80, O114:K90, O142:K86, O164 and O157. Nine of the virulence factors have been explored, ibeA, pap, sfa/foc, cnf1, hly, fyuA, pil, ompT and traT. Virulence factors profiling of the isolates revealed a different content ranging from 22% to 100% of the virulence genes explored. The pathogenic capacity of all fifteen isolates when tested on Vero cells showed that the cytotoxicity for all tested strains on Vero cells was approximately equal and enhanced after growth in syncase broth, leading mainly to cell lysis. The toxic effects reduced slightly after heat treatment of the toxin, and greatly after formalin detoxification, but not all the deleterious effect was abolished. Endotoxin also has cytotoxic effects on Vero cells, but longer time is needed for cytolysis which is greatly diminished with formalin treatment. In conclusion, our study revealed that pathogenic strains of UPEC can exert their pathogenic effect on live cells or system with limited virulence factors gene content.

Słowa kluczowe

EN

uropathogenic isolate; Escherichia coli; isolate; virulence gene; pathological influence; Vero cell; urinary tract infection

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2014
• Tom: 63
• Numer: 1
• Opis fizyczny: p.43-49,fig.,ref.

Twórcy

autor

Obaid J.M.A.S.

• Medical Research Institute, Alexandria University, 151 Abdelnaser St., Alexandria, Egypt

autor

Monsour S. R.

• Faculty of Science, Suez Canal University, Egypt

autor

Elshahedy M. S.

• Faculty of Veterinary Medicine, Suez Canal University, Egypt

autor

Rabie T. E.

• Faculty of Agriculture, Suez Canal University, Egypt

autor

Azab A. M. H.

• Veterinary Serum and Vaccine Research Institute Abbasia-Cairo, Egypt

Bibliografia

• Abdullah A.A. and M.I. Al-Moslih. 2005. Prevalence of asymptomatic bacteriuria in pregnant women in Sharjah, United Arab Emirates. East Mediterr. Health J. 11: 1045–1052.
• Ananias M. and T. Yano. 2008. Serogroups and virulence genotypes of Escherichia coli isolated from patients with Sepsis. Braz. J. Med. Biol. Res. 41: 877–883.
• Bisi-Johnson M.A., C.L Obi, S.D. Vasaikar, K.A. Baba and T. Hattori. 2011. Molecular basis of virulence in clinical isolates of Escherichia coli and Salmonella species from a tertiary hospital in the Eastern Cape, South Africa. Gut Pathog. 3: 9.
• Caprioli A., V. Falbo, L.G. Roda, F.M. Ruggeri and C. Zona. 1983. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect. Immun. 39: 1300–1306.
• Carbonell G.V., A.F. Alfieri, A.A.M. Alfieri, M.C. Vidotto,C.E. Levy, A.L.C. Darini and R.M. Yanaguita. 1997. Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marcescens. Braz. J. Med. Biol. Res. 30: 1291–1298.
• Cheesbrough M. 1993. Medical laboratory manual for tropical countries, vol II. 2nd ed. ELBS, University Press Cambridge, Great Britain.
• Clugston R.E. and N.O. Nielsen. 1974. Experimental edema disease of swine (E. coli Enterotoxemia). I. Detection and preparation of an active principle. Can. J. Comp. Med. 38: 22–28.
• Gonzalez R., C. Diaz, M. Marino, R. Cloralt, M. Pequeneze and I. Perez-Schael. 1997. Age-specific prevalence of Escherichia coli with localized and aggregative adherence in Venezuelan infants with acute diarrhea. J. Clin. Microbiol. 35: 1103–1107.
• Hagan E.C. and H.L. Mobley. 2007. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect. Immun. 75: 3941–3949.
• Hentschel U., M. Steinert and J. Hacker. 2000. Common molecular mechanisms of symbiosis and pathogenesis. Trends Microbiol. 8: 226–231.
• Johnson J.R., T.T. O’Bryan, D.A Low., G. Ling, P. Delavari,C. Fasching, T.A Russo, U. Carlino and A.L. Stell. 2000. Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele 3. Infect. Immun. 68: 3327–3336.
• Johnson J.R. and A.L. Stell. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relationto phylogeny and host compromise. J. Infect. Dis. 181: 261–273.
• Johnson R.J., K. Owens, A. Gajewski and M.A. Kuskowski. 2005. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J. Clinic. Microbiol. 43: 6064–6072.
• Justice S.S., C. Hung, J.A. Theriot, D.A. Fletcher, G.G. Anderson, M.J. Footer and S.J. Hultgren. 2004. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. PNAS 101: 1333–1338.
• Kaper J.B., J.P. Nataro and H.L. Mobley. 2004 Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2: 123–140.
• Klapproth J.A., I.C.A.Scaletsky, B.P. Mcnamara, L. Lai, C. Malstrom, S.P. James and M.S. Donnenberg. 2000. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect. Immun. 68: 2148–2155.
• Klemm P., V.Hancock and M.A. Schembri. 2007. Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect. Immun. 75: 3688–3695.
• Landraud L., C.Pulcini, P.Gounon, G. Flatau, P.Boquet andE. Lemichez. 2004. E. coli CNF1 toxin; a two-in-one system for host-cell invasion. Int. J. Med. Microbiol. 293: 513–518.
• Marquis H., V. Doshi and D.A. Portnoy. 1995. The broad-range phospholipase C and a metalloprotease mediate listeriolysin O-independent escape of Listeria monocytogenes from a primary vacuole in human epithelial cells. Infect. Immun. 63: 4531–4534.
• Mulvey M.A. 2002. Adhesion and entry of uropathogenic Escherichia coli. Cell. Microbiol. 4: 257–271.
• Nandy P., A.R.Thakur and S.R. Chaudhuri. 2007. Characterization of bacterial strains isolated through microbial profiling of urine samples. J. Biol. Sci. 7: 44–51.
• Olesen B., H.J. Komos, F. Orskov and I. Orskov. 1994. Cluster of multiresistant Escherichia coli O78:H10 in Greater Copenhagen. Scand. J. Infect. Dis. 26: 406–410.
• Ørskov F. and I. Ørskov. 1984. Serotyping of Escherichia coli.Methods Microbiol. 14: 43–112.
• Osek J., M. Lebens and J. Holmgren. 1995. Improved medium for large-scale production of recombinant cholera toxin B subunit for vaccine purposes. J. Microbiol. Methods 24: 117–123.
• Scheutz F. and N. Strockbine. 2001. Genus Escherichia, In:Bergey’s manual of Systematic Bacteriology, 2nd ed. volume 2 part B, Springer USA.
• Schilling J.D., M.A. Mulvey and S.J. Hultgren. 2001. Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 57(6 Suppl 1): 56–61.
• Schmidt H. and M. Hensel. 2004. Pathogenicity islands in bacterial pathogenesis. Clin. Microbiol. Rev. 17: 14–56.
• Slavchev G., E. Pisareva and N. Markova. 2009. Virulence of uropathogenic Escherichia coli. J. Cult. Collect. 6: 3–9.
• Speirs J.I., S. Stavric and J. Konowalchuk. 1997. Assay of Escherichia coli heat-labile enterotoxin with Vero cells. Infect. Immun. 16: 617–622.
• Swiatczak B., M. Rescigno and I.R. Cohen. 2011. Systemic features of immune recognition in the gut. Microbes Infect. 13:983–991.
• Takahashi A., S. Kanamaru, H. Kurazono, Y. Kunishima,Y. Tsukamoto, O. Ogawa and S. Yamamoto. 2006. Escherichia coli isolates associated with uncomplicated and complicated cystitisand asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J. Clinic. Microbiol. 44: 4589–4592.
• Tseng C.C., J.J. Huang, W.C. Ko, J.J. Yan and J.J. Wu. 2001. Decreased predominance of papG class 2 allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities. J. Urol. 166: 1643–1646.
• Vranes J., S. Schonwald, N. Sterk-Kuzmanoviæ and B. Ivanèiæ. 2001. Low virulence of Escherichia coli strains causing exacerbation of chronic pyelonephritis. Acta clin. Croat. 40: 165–170.
• Williams P.J. and M. Parasuraman. 2001. Urine. In: Myer’s and Koshi’s Manual of Diagnostic Procedures in Medical Microbiology and Immunology/Serology. Vellore: Department of Microbiology, Christian Medical College and Hospital. pp. 57–62.
• Wullt B. 2002. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int.J. Antimicrob. Agents 221: 605–621.
• Yamamoto S., A. Terai K. Yuri H. Kurazono Y. Takeda andO. Yoshida. 1995. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol. Med. Microbiol. 12: 85–90.